<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1303257050
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2013
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        ZYMAXID 0.5% eye drops solution
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        GATIFLOXACIN
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        0.5
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Ophthalmic use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Ophthalmic solution
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        2
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Dropper Container
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        NCE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 25°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        28.35
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="ALLERGAN" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            ALLERGAN
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 359]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Cigalah Group
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            AbbVie Inc
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        S01AE06
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>ZYMAXID&nbsp;<strong>&nbsp;</strong>is a quinolone antimicrobial indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms:</p><p><em>Haemophilus influenzae, Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus mitis </em>group<em>, Streptococcus oralis, Streptococcus pneumoniae</em></p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>D</strong><strong>o not use </strong><strong>ZYMAXID</strong></p><p>&nbsp;ZYMAXID&nbsp;is contraindicated in patients with a history of hypersensitivity to gatifloxacin, to other quinolones, or to any of the components in this medication.</p><p>&nbsp;</p><p><strong>Tak</strong><strong>e special care with </strong><strong>ZYMAXID</strong></p><p>&nbsp;If an allergic reaction against gatifloxacin occurs. This allergic reaction may occur as swelling of the face, increased heart rhythm, breathing difficulty, and rash. If you experience an allergic reaction, immediately discontinue the drug and contact your doctor.</p><p>As with other antibiotics, prolonged use may result in overgrowth of non-susceptible organisms including fungi. In such case stop using this drug and consult your doctor.</p><p>If you have infection in the eye, do not use contact lens.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p>If you wear contact lenses. Do not use ZYMAXID&nbsp;while your contact lenses are in your eyes.</p><p>&nbsp;</p><p><strong>Usin</strong><strong>g other medicines, herbal or dietary supplements</strong></p><p>If you need to instill more than one drop to your eye as a medicine, wait for 15 minutes between instilling two separate medicines. Antibiotic group of ZYMAXID&nbsp;has been reported to interact with some medicines that are orally administered.</p><p>Please inform your doctor or pharmacist if you are taking or have recently taken any other medicines.</p><p>&nbsp;</p><p><strong>Preg</strong><strong>nancy and breast-feeding</strong></p><p>Ask your doctor, healthcare provider or pharmacist for advice before taking any medicine.</p><p>&nbsp;</p><p>Pregnancy:&nbsp; &nbsp; &nbsp;</p><p>Ask your doctor or pharmacist for advice before taking ZYMAXID.</p><p>The doctor should decide on the use of the medication taking into account the risk/benefit ratio.</p><p>If you realize that you are pregnant during your treatment, inform your doctor or pharmacist immediately.</p><p>&nbsp;</p><p>Breast-feeding:</p><p>Ask your doctor or pharmacist for advice before taking ZYMAXID.</p><p>The doctor should decide on the use of the medication taking into account the risk/benefit ratio.</p><p>&nbsp;</p><p><strong>Driving and using machines</strong></p><p>If temporary blurred vision occurs during installation, wait until your vision becomes clear before driving or using machines.</p><p>&nbsp;</p><p><strong>Important information about certain excipients in the composition of ZYMAXID</strong></p><p>ZYMAXID&nbsp;&nbsp;contains benzalkonium chloride as a preservative which may be deposited in soft contact lenses, therefore this product should not be used while wearing these lenses. These lenses should be removed before application of this product and not re-inserted earlier than 15 minutes after use.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always use ZYMAXID &nbsp;exactly as your doctor or healthcare provider has told you. You should check with your doctor, healthcare provider or pharmacist if you are not sure.</p><p>&nbsp;</p><p><strong>Instru</strong><strong>c</strong><strong>tion</strong><strong>s for proper use Dosage:</strong></p><p>ZYMAXID is administered topically to the eye.</p><p>&middot;&nbsp;&nbsp;Day 1: Instill one drop every two hours in the affected eye(s) while awake, up to 8 times.</p><p>&middot;&nbsp;&nbsp;Day 2 through Day 7:&nbsp; Instill one drop two to four times daily in the affected eye(s) while awake.</p><p>&nbsp;</p><p><strong>Met</strong><strong>h</strong><strong>o</strong><strong>d of administration</strong></p><p><strong><img alt="" width="570" height="238" src="data:image/png;base64,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" /></strong></p><p>1.&nbsp; &nbsp; &nbsp; W ash your hands before using your medication. Tilt your head back and look up.</p><p>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pull down your lower eyelid slowly to create a small pocket.</p><p>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turn the bottle upside down and squeeze it such that one drop is put into each eye which should be treated.</p><p>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Release you eyelid and</p><p>&nbsp;</p><p>keep your eyes closed for 30 second .</p><p>If a drop misses your eye, try again.</p><p>To keep the eye drops free from contamination, do not let the tip of the single use vial touch your eye or anything else</p><p>&nbsp;</p><p>Pediatric Use:</p><p>The safety and effectiveness of ZYMAXID<strong><sup> </sup></strong>in infants below one year of age have not been established.&nbsp; ZYMAXID has been demonstrated in clinical trials to be safe and effective for the treatment of bacterial conjunctivitis in pediatric patients one year or older.</p><p>&nbsp;</p><p>Geriatric Use:</p><p>No dose adjustment is needed for elderly patients</p><p>&nbsp;</p><p><strong>If you take more</strong><strong> ZYMAXID</strong><strong> </strong><strong>t</strong><strong>h</strong><strong>a</strong><strong>n you should</strong></p><p>If you take more ZYMAXID than you should, consult your doctor, health provider or pharmacist</p><p><strong>&nbsp;</strong></p><p><strong>If you forget to take ZYMAXID</strong></p><p>If you forget a dose apply it as soon as you remember, unless it is almost time for your next dose, in which case you should miss out the forgotten dose. Then take your next dose as usual and continue with your normal routine.</p><p>Do not take a double dose to make up for a forgotten dose.</p><p>&nbsp;</p><p><strong>If you stop using ZYMAXID</strong></p><p>Discontinuation of ZYMAXID therapy is not expected to create a negative effect.</p><p>&nbsp;</p><p>If you have any further questions on the use of this product, ask your doctor, healthcare provider or pharmacist.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, ZYMAXID can cause side effects, although not everybody gets them.</p><p>Common:</p><ul><li>worsening of the conjunctivitis.</li><li>eye irritation.</li><li>dysgeusia.</li><li>eye pain.&nbsp;</li></ul><p>&nbsp;</p><p>Additional adverse reactions reported with other formulations of gatifloxacin ophthalmic solution in other clinical studies included:</p><p>Common:</p><ul><li>Chemosis.</li><li>conjunctival hemorrhage.</li><li>dry eye.&nbsp; &nbsp;&nbsp;</li><li>eyelid edema.</li><li>Headache.</li><li>increased lacrimation.</li><li>reduced visual acuity.</li></ul><p>&nbsp;</p><p>Uncommon:</p><ul><li>eye discharge.</li><li>Keratitis.</li><li>red eye.</li><li>papillary conjunctivitis.</li></ul><p>&nbsp;</p><p>Unknown frequency:</p><p>The following adverse reactions have been identified during post-approval use of ZYMAXID<strong><sup> </sup></strong>or with other formulations of gatifloxacin ophthalmic solution. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.&nbsp; These reactions included anaphylactic reactions and angioedema (including pharyngeal, oral or facial edema), blepharitis, dyspnea, eye pruritus, eye swelling (including corneal and conjunctival edema), hypersensitivity, including signs and symptoms of eye allergy and allergic dermatitis, nausea, pruritus (including pruritus generalized, rash, urticaria), and vision blurred.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep out of the reach and sight of children</p><p>Store at 15&deg;-25&deg;C . Protect from freezing.</p><p>Discard 28 days after first opening</p><p>Do not use ZYMAXID &nbsp;after the expiry date which is stated on the package. The expiry date refers to the last day of that month.</p><p>Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The active substance is gatifloxacin 0.5 %.</p><p>The other ingredients are benzalkonium chloride 0.005%, edetate disodium, sodium chloride, purified water and hydrochloric acid and/or sodium hydroxide to adjust pH.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                ZYMAXID (gatifloxacin ophthalmic solution) 0.5% is supplied sterile in a white, low density   polyethylene (LDPE) bottle with a controlled dropper tip, and a tan, high impact polystyrene (HIPS) cap in the following size:
2.5 mL in 5 mL bottle

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>a.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>Marketing Authorization Holder:</strong></p><p>Allergan Inc.</p><p>Irvine, USA</p><p>Telephone: 800-347-4500</p><p>Fax: (714) 796-3015</p><p><strong>Manufacturer: </strong></p><p>Allergan Sales LLC, Waco, USA</p><p>Telephone: (254) 666-8660</p><p>Fax: (254) 666-3012</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This leaflet was prepared in 09/2016
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>زيماكسيد هو دواء مضاد للميكروبات يحتوي على مادة كوينولون ويُستخدم لعلاج التهاب الملتحمة البكتيري الناتج عن السلالات السريعة التأثر من الكائنات التالية</p><p>المستدمية النزلية، العنقودية الذهبية، المكورات العنقودية البشروية، مجموعة العِقْدِيّات&nbsp;الهينة، العِقْدِيَّةُ&nbsp;الفموية، العِقْدِيَّةُ&nbsp;الرئوية</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><strong>يحظر استعمال زيماكسيد</strong></p><p>يُحظر استعمال زيماكسيد&reg; للمرضى الذين يعانون من حساسية مفرطة تجاه مادة جاتيفلوكساسين أو أي كينولونات أو مكونات أخرى موجودة في هذا الدواء</p><p><strong>&nbsp;</strong></p><p><strong>توخى الحرص الشديد عند استخدام زيماكسيد</strong></p><p>عند حدوث حساسية ناتجة عن التفاعل مع مادة جاتيفلوكساسين، وقد يتسبب هذا التفاعل في حدوث تورم في الوجه وزيادة ضربات القلب وصعوبة في التنفس وطفح جلدي. في حال ظهور حساسية ناتجة عن التفاعل، توقف على الفور عن استخدام العقار واتصل بطبيبك</p><p>كما الحال مع المضادات الحيوية الأخرى، قد يؤدي الاستخدام لمدة طويلة إلى زيادة نمو بعض الكائنات التي لا تتأثر سريعاً مثل الفطريات. في هذه الحالة توقف عن استخدام هذا العقار واستشر طبيبك</p><p>إذا كنت مصاباً بعدوى في العين، يحظر استخدام العدسات اللاصقة</p><p>إذا كنت مرتدياً عدسات لاصقة. لا تستخدم زيماكسيد&reg; والعدسات اللاصقة داخل عينيك</p><p><strong>&nbsp;</strong></p><p><strong>استخدام الأدوية الأخرى أو الأعشاب أو المكملات الغذائية&nbsp;</strong></p><p>إذا كنت بحاجة إلى استخدام أكثر من نوع واحد من قطرات العين، انتظر لمدة 15 دقيقة كفاصل زمني بين كل قطرة وأخرى. لقد وردت تقارير تفيد بحدوث تفاعل بين مجموعة المضادات الحيوية من زيماكسيد<strong> </strong>مع بعض الأدوية التي تؤخذ عن طريق الفم.</p><p>يُرجى إبلاغ الطبيب أو موفر الرعاية الصحية أو الصيدلي إذا كنتَ تتناول حالياً أو تناولت مؤخراً أدوية أخرى</p><p>&nbsp;</p><p><strong>الحمل والرضاعة</strong></p><p>استشيري طبيبكِ أو موفر الرعاية الصحية أو الصيدلي قبل أخذ أي دواء</p><p><strong>&nbsp;</strong></p><p>الحمل</p><p>استشيري طبيبك أو الصيدلي قبل أخذ زيماكسيد</p><p>يجب أن يقرر الطبيب مع الأخذ في الاعتبار نسبة المخاطر/ الفوائد</p><p>إذا كنتِ تعتقدين أنكِ حاملاً خلال فترة العلاج، أخبري طبيبك أو الصيدلي على الفور</p><p>الرضاعة الطبيعية</p><p>استشيري طبيبك أو الصيدلي قبل أخذ زيماكسيد</p><p>يجب أن يقرر الطبيب استخدامكِ للدواء، مع أخذ نسبة المخاطر/الفوائد بعين الاعتبار</p><p><strong>&nbsp;</strong></p><p><strong>القيادة وتشغيل الآلات</strong></p><p>في حال حدوث غشاوة مؤقتة في الرؤية عند وضع القطرة ، انتظر حتى تصبح الرؤية واضحة قبل القيادة استخدام الآلات أو القيادة</p><p><strong>&nbsp;</strong></p><p><strong>معلومات مهمة عن بعض المكونات غير الأساسية في تركيبة زيماكسيد</strong></p><p>يحتوي زيماكسيد&nbsp;على كلوريد البنزالكونيوم كمادة حافظة والتي قد تترسب في العدسات اللاصقة اللينة، ولذلك يجب عدم استخدام هذا المنتج أثناء ارتداء هذه العدسات. يجب إزالة هذه العدسات قبل استخدام هذا المنتج وعدم ارتدائها مجدداً قبل 15 دقيقة بعد الاستخدام.</p><p><strong>&nbsp;</strong></p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>استخدم زيماكسيد دائماً وفقاً لإرشادات الطبيب أو موفر الرعاية الصحية. يجب استشارة الطبيب أو موفر الرعاية الصحية أو الصيدلي إذا لم تكن متأكداً</p><p><strong>&nbsp;</strong></p><p><strong>إرشادات الاستخدام الصحيح</strong></p><p><strong>الجرعة</strong></p><p>توضع قطرة<strong> </strong>زيماكسيد&reg; موضعياً في العين</p><p>اليوم الأول: ضع قطرة واحدة كل ساعتين في كل عين مصابة وأنت مستيقظ، حتى 8 مرات</p><p>اليوم الثاني حتى اليوم السابع: ضع قطرة واحدة مرتين إلى أربع مرات يومياً في كل عين مصابة وأنت مستيقظ</p><p>&nbsp;</p><p><strong>طريقة الاستخدام</strong></p><p><strong><img alt="" width="560" height="234" src="data:image/png;base64,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" /></strong></p><p>&nbsp;</p><p>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;اغسل يديك قبل استخدام دوائك. أمل رأسك إلى الوراء وانظر إلى أعلى</p><p>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;اسحب جفنك السفلي ببطء لتكوين جيب صغير</p><p>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;اقلب الزجاجة من أعلى إلى أسفل واضغط عليها بحيث تخرج قطرة واحدة في كل عين تحتاج إلى علاج</p><p><strong>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</strong>حرر جفنك واغلق عينيك لمدة 30 ثانية</p><p><strong>&nbsp;</strong></p><p>إذا لم تدخل القطرة داخل عينك، فكرر المحاولة مرة أخرى<strong>&nbsp;</strong></p><p>للحفاظ على قطرة العين من التلوث، لا تدع طرف الزجاجة المخصصة للاستخدام مرة واحدة يلمس عينك أو أي شيء آخر</p><p>&nbsp;</p><p>الاستخدام مع الأطفال</p><p>لم تثبت سلامة المحلول وفاعليته مع المرضى من الأطفال الذين تقل أعمارهم عن عام واحد</p><p>خلال التجارب السريرية، قد ثبتت سلامة محلول زيماكسيد&nbsp;وفاعليته في علاج التهاب الملتحمة البكتيري لدى المرضى من الأطفال البالغ أعمارهم عام واحد أو أكثر</p><p><strong>&nbsp;</strong></p><p>الاستخدام مع كبار السن</p><p>لا تحتاج الجرعة إلى تعديل عندما يستخدمها كبار السن</p><p><strong>&nbsp;</strong></p><p><strong>في حال أخذ جرعة زائدة من زيماكسيد</strong></p><p>في حال أخذ جرعة زائدة من زيماكسيد، استشر الطبيب أو موفر الرعاية الصحية أو الصيدلي</p><p><strong>&nbsp;</strong></p><p><strong>في حال غفلت عن أخذ زيماكسيد</strong></p><p>إذا نسيت أخذ إحدى الجرعات، فخذها بمجرد تذكرك، إلا إذا اقترب موعد أخذ الجرعة التالية؛ ففي هذه الحالة لا تأخذ الجرعة الفائتة. ثم خذ جرعتك التالية في وقتها المعتاد وواصل روتينك الطبيعي<strong>&nbsp;</strong></p><p>لا تأخذ جرعة مضاعفة لتعويض الجرعة التي نسيتها</p><p><strong>&nbsp;</strong></p><p><strong>في حالة التوقف عن استخدام زيماكسيد</strong></p><p><strong>&nbsp;</strong>من غير المتوقع أن يتسبب التوقف عن أخذ زيماكسيد في إحداث تأثير سلبي</p><p>إذا كان لديك مزيد من الأسئلة حول استخدام هذا المنتج، اسأل الطبيب أو موفر الرعاية الصحية أو الصيدلي</p><p><strong>&nbsp;</strong></p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>كما الحال مع جميع الأدوية الأخرى، قد ينتج عن استخدام زيماكسيد&reg; آثار جانبية، بالرغم من عدم ظهورها على جميع الأشخاص</p><p><strong>&nbsp;</strong></p><p>:آثار جانبية شائعة</p><p>&nbsp; &nbsp; &nbsp; تدهور التهاب الملتحمة</p><p>&nbsp; &nbsp; &nbsp; تهيج العين</p><p>اختلال حاسة التذوق</p><p>&nbsp; &nbsp; &nbsp;ألم داخل العين</p><p>:أظهرت دراسات سريرية أخرى حدوث المزيد من التفاعلات السلبية مع التركيبات الأخرى لمحلول قطرة العين الذي يحتوي على جاتيفلوكساسين ومنها</p><p>:آثار جانبية شائعة</p><p>وذمة (تورم) الملتحمة</p><p>نزيف داخل ملتحمة العين</p><p>جفاف العين</p><p>وذمة (تورم) في الجفن</p><p>صداع</p><p>كثرة إفراز الدموع</p><p>انخفاض دقة الإبصار</p><p>&nbsp;</p><p>:آثار جانبية غير شائعة</p><p>زيادة إفرازات العين</p><p>التهاب القرنية</p><p>احمرار العين</p><p>التهاب الملتحمة الحليمي</p><p><strong>&nbsp;</strong></p><p>:آثار جانبية غير معروف معدل تكرارها</p><p>لقد تم تحديد التفاعلات السلبية التالية بعدما تم التصديق على استخدام زيماكسيد&reg; أو عند استخدامه مع تركيبات أخرى لمحلول عيون يحتوي على جاتيفلوكساسين. وحيث تم الإبلاغ عن حدوث هذه التفاعلات بشكلٍ تطوعي من جانب مجموعة من الأشخاص غير المحددة العدد، فليس من الممكن دائماً تقدير معدل تكرار حدوثها بشكل موثوق به أوالربط بين حدوثها واستخدام العقار. ومن بين هذه التفاعلات نجد التفاعلات التَأَقِيّة، والوذمة الوعائية (مثل الوذمة البلعومية أو الوذمة الفموية أو وذمة الوجه)، والتهاب جفني العين، وضيق النفس، وحكة في العينين، وتورم العينين (بما في ذلك وذمة القرنية ووذمة ملتحمة العين)، وفرط الحساسية. وتشمل علامات وأعراض حساسية العين والحساسية الناتجة عن التهاب الجلد: الغثيان، الحكة (وتشمل الشعور العام بالحكة، والطفح الجلدي، والشَرَى)، والرؤية الضبابية.</p><p><strong>&nbsp;</strong></p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>يُحفَظ بعيداً عن متناول الأطفال ومرمى بصرهم<strong>&nbsp;</strong></p><p>يُحفظ في درجة حرارة أقل من 15&deg;-25&deg; مئوية. تجنب تجمد المحلول</p><p>يتعين التخلص من المنتج بعد انقضاء 28 يوماً من فتحه لأول مرة</p><p>لا تستخدم زيماكسيد بعد تاريخ انتهاء الصلاحية المدون على العبوة. يشير تاريخ الصلاحية إلى اليوم الأخير من الشهر المذكور</p><p>يحظر التخلص من الأدوية عن طريق مياه الصرف أو النفايات المنزلية. سل الصيدلي عن طريقة التخلص من الأدوية التي لم تعد تحتاج إليها. تساعد هذه التدابير في حماية البيئة</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>%0.5المادة الفعالة هي جاتيفلوكساسين&nbsp;</p><p>المكونات الأخرى كلوريد بنزالكونيوم 0.005%، وإيديتات ثنائي الصوديوم، وكلوريد صوديوم، وماء نقي، وحمض هيدروكلوريك و/ أو هيدروكسيد صوديوم لضبط درجة الحموضة</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            يتوفر زيماكسيد (جاتيفلوكساسين محلول عيون) 0.5% في شكل محلول معقم يأتي في زجاجة بيضاء مصنوعة من مادة البولي إثيلين المنخفضة الكثافة (LDPE)  ومزودة بقطارة يمكن التحكم بها وبغطاء مصنوع من مادة البولي ستيرين العالي التأثير (HIPS)، وتأتي العبوة في الحجم المذكور أدناه:
2.5 مل في زجاجة 5 مل

        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p><strong>:الشركة صاحبة ترخيص التسويق</strong></p><p>شركة أليرجان</p><p>إرفاين، الولايات المتحدة الأمريكية</p><p>هاتف رقم: 800-347-4500</p><p>فاكس: 3015-796 (714)</p><p><strong>&nbsp;&nbsp;</strong></p><p><strong>:الشركة المُصنعة</strong></p><p>أليرجان للمبيعات ذ.م.م، واكو، الولايات المتحدة الأمريكية</p><p>هاتف رقم: 8660-666 (254)</p><p>فاكس: 3012-666 (254)</p><p><strong>&nbsp;</strong></p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            أُعدت هذه النشرة في 09/2016
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                ZYMAXID® (gatifloxacin ophthalmic solution) 0.5% for topical ophthalmic use.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Active substance: 
0.5% gatifloxacin (5mg/mL)

Excipients
Benzalkonium Chloride 0.05 mg/ml
 Full list of excipients, see section 6.1

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Sterile ophthalmic solution.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>ZYMAXID is indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Aerobic gram-positive bacteria:</p><p><em>Staphylococcus aureus</em></p><p><em>Staphylococcus epidermidis</em></p><p><em>Streptococcus mitis </em>group<em>*</em></p><p><em>Streptococcus oralis*</em></p><p><em>Streptococcus pneumoniae</em></p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Aerobic gram-negative bacteria:</p><p><em>Haemophilus influenzae</em></p><p>&nbsp;</p><p>*Efficacy for these organisms were studied in fewer than 10 infections<em>.</em></p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>ZYMAXID is administered topically to the eye.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Day 1: Instill one drop every two hours in the affected eye(s) while awake, up to 8 times.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Day 2 through Day 7:&nbsp; Instill one drop two to four times daily in the affected eye(s) while awake.</p><p><strong>&nbsp;</strong></p><p><strong>Pediatric Use</strong></p><p>The safety and effectiveness of ZYMAXID in infants below one year of age have not been established. &nbsp;ZYMAXID has been demonstrated in clinical trials to be safe and effective for the treatment of bacterial conjunctivitis in pediatric patients one year or older.</p><p>&nbsp;</p><p><strong>Geriatric Use</strong></p><p>No overall differences in safety or effectiveness have been observed between elderly and younger patients.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                ZYMAXID is contraindicated in patients with a history of hypersensitivity to gatifloxacin, to other quinolones, or to any of the components in this medication.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Hypersensitivity</strong></p><p>Some patients receiving topical ophthalmic gatifloxacin experienced hypersensitivity reactions including anaphylactic reactions, angioedema (including pharyngeal, laryngeal, or facial edema), dyspnea, urticaria, and itching, even following a single dose.&nbsp; Rare cases of Stevens-Johnson Syndrome were reported in association with topical ophthalmic gatifloxacin use.&nbsp; If an allergic reaction to gatifloxacin occurs, discontinue the drug <em>[see Patient Counseling Information (17)].</em></p><p><strong>&nbsp;</strong></p><p><strong>Growth of Resistant Organisms with Prolonged Use</strong></p><p>Prolonged use of ZYMAXID&nbsp;may result in overgrowth of nonsusceptible organisms, including fungi. If superinfection occurs, discontinue use and institute alternative therapy.&nbsp; Whenever clinical judgment dictates, examine the patient with the aid of magnification, such as slit lamp biomicroscopy and where appropriate, fluorescein staining.</p><p><strong>&nbsp;</strong></p><p><strong>Corneal Endothelial Cell Injury</strong></p><p>ZYMAXID&nbsp;is for topical ophthalmic use.&nbsp; ZYMAXID&nbsp;may cause corneal endothelial cell injury if introduced directly into the anterior chamber of the eye.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Specific drug interaction studies have not been conducted with ZYMAXID&nbsp;ophthalmic solution</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Fertility</strong></p><p>Oral administration of gatifloxacin produced no adverse effects on fertility or reproduction in rats at doses up to 200 mg/kg/day (approximately 800-fold higher than the MRHOD, on a mg/m<sup>2</sup> basis).</p><p>&nbsp;</p><p><strong>Pregnancy&nbsp;</strong></p><p>Pregnancy Category: &nbsp;C</p><p>&nbsp;There are no available data on the use of ZYMAXID in pregnant women to inform a drug‑associated risk. Administration of oral gatifloxacin to pregnant rats and rabbits throughout organogenesis did not produce adverse development outcomes at clinically relevant doses.&nbsp; Administration of gatifloxacin to rats during late gestation through lactation did not produce adverse maternal, fetal or neonatal effects at clinically relevant doses.</p><p>&nbsp;</p><p><u>Data</u></p><p><em>Animal Data</em></p><p>Oral administration of gatifloxacin to pregnant rats throughout organogenesis produced teratogenic effects in rat fetuses, including skeletal/craniofacial malformations, delayed ossification, atrial enlargement, and reduced fetal weight, at doses greater than or equal to 150&nbsp;mg/kg/day (approximately 600-fold higher than the maximum recommended human ophthalmic dose [MRHOD] for ZYMAXID of 0.04 mg/kg/day, on a mg/m<sup>2</sup> basis).&nbsp; No teratogenic effects were observed in rat or rabbit fetuses at doses of gatifloxacin up to 50 mg/kg/day (approximately 200‑ and 400-fold higher than the MRHOD, respectively, on a mg/m<sup>2</sup> basis).&nbsp;</p><p>In a perinatal/postnatal study in rats, oral administration of gatifloxacin during late gestation through lactation produced an increase in late gestation fetal loss and neonatal/perinatal mortality at 200&nbsp;mg/kg/day (approximately 800-fold higher than the MRHOD on a mg/m<sup>2</sup> basis).</p><p><strong>&nbsp;</strong></p><p><strong>2&nbsp;&nbsp; Lactation</strong></p><p>There is no information regarding the presence of ZYMAXID&nbsp;in human milk, the effect of gatifloxacin on breastfed infants, or the effect of gatifloxacin on milk production.&nbsp; Gatifloxacin was found in the breast milk of rats following oral administration of gatifloxacin during lactation.&nbsp; However, systemic levels of gatifloxacin following topical ocular administration are low <em>[see Clinical Pharmacology (12.3)],</em> and it is not known whether gatifloxacin would be present in maternal milk at measurable levels following topical ocular administration.&nbsp; The developmental and health benefits of breastfeeding should be considered along with the mother&rsquo;s clinical need for ZYMAXID and any potential adverse effects on the breastfed child from ZYMAXID.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>As with any ocular medication, if transient blurred vision occurs at instillation, the patient should wait until the vision clears before driving or using machinery &nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Clinical Studies Experience</strong></p><p>Because clinical studies are conducted under widely varying conditions, adverse reaction rates observed in the clinical studies of a drug cannot be directly compared to rates in the clinical studies of another drug and may not reflect the rates observed in practice.</p><p><strong>&nbsp;</strong></p><p>In clinical studies of patients with bacterial conjunctivitis treated with ZYMAXID&nbsp;(N=717), the most frequently reported adverse reactions occurring patients were:&nbsp;</p><p>Common:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; worsening of the conjunctivitis.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; eye irritation.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; dysgeusia.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; eye pain.&nbsp;</p><p>&nbsp;</p><p>Additional adverse reactions reported with other formulations of gatifloxacin ophthalmic solution in other clinical studies included:</p><p>Common:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Chemosis.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; conjunctival hemorrhage.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; dry eye. &nbsp;&nbsp;&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; eyelid edema.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Headache.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; increased lacrimation.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; reduced visual acuity.</p><p>&nbsp;</p><p>Uncommon:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; eye discharge.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Keratitis.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; red eye.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; papillary conjunctivitis.</p><p>&nbsp;</p><p><strong>Postmarketing Experience</strong></p><p>The following adverse reactions have been identified during post-approval use of ZYMAXID&nbsp;or with other formulations of gatifloxacin ophthalmic solution. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.&nbsp; These reactions included anaphylactic reactions and angioedema (including pharyngeal, oral or facial edema), blepharitis, dyspnea, eye pruritus, eye swelling (including corneal and conjunctival edema), hypersensitivity, including signs and symptoms of eye allergy and allergic dermatitis, nausea, pruritus (including pruritus generalized, rash, urticaria), and vision blurred.</p><p>&nbsp;</p><p>To report any side effect(s) Saudi Arabia:</p><p>The National Pharmacovigilance and Drug Safety Centre (NPC) Fax: +966-11-205-7662</p><p>o Call NPC at +966-11-2038222, Exts: 2317-2356-2353-2354-2334-2340.</p><p>o Toll free phone: 8002490000</p><p>o E-mail: npc.drug@sfda.gov.sa Website: www.sfda.gov.sa/npc</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>ZYMAXID is intended for topical use only. Due to the low systemic concentrations after topical ophthalmic application, the likelihood of systemic intoxication from topical overdose is remote.</p><p>In the event of accidental ingestion, the patient should be carefully observed, and give symptomatic and support treatment.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Opthalmics, other antiinfectives</p><p>ATC Code: S01AE06</p><p><strong>&nbsp;</strong></p><p><strong>Mechanism of Action</strong></p><p>Gatifloxacin is a quinolone antimicrobial</p><p>Gatifloxacin is an 8-methoxyfluoroquinolone with a 3-methylpiperazinyl substituent at C7. The antibacterial action of gatifloxacin results from inhibition of DNA gyrase and topoisomerase IV. DNA gyrase is an essential enzyme that is involved in the replication, transcription, and repair of bacterial DNA. Topoisomerase IV is an enzyme known to play a key role in the partitioning of the chromosomal DNA during bacterial cell division. The mechanism of action of fluoroquinolones including gatifloxacin is different from that of aminoglycoside, macrolide, and tetracycline antibiotics.&nbsp; Therefore, gatifloxacin may be active against pathogens that are resistant to these antibiotics and these antibiotics may be active against pathogens that are resistant to gatifloxacin.&nbsp; There is no cross-resistance between gatifloxacin and the aforementioned classes of antibiotics.&nbsp; Cross-resistance has been observed between systemic gatifloxacin and some other fluoroquinolones.</p><p>Resistance to gatifloxacin <em>in vitro </em>develops via multiple-step mutations.Resistance to gatifloxacin <em>in vitro</em> occurs at a general frequency of 1 x 10<sup>-7</sup> to 10<sup>-10</sup>.</p><p>Gatifloxacin has been shown to be active against most isolates of the following organisms both microbiologically and clinically, in conjunctival infections:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Aerobic gram-positive bacteria:</p><p><em>Staphylococcus aureus</em></p><p><em>Staphylococcus epidermidis</em></p><p><em>Streptococcus mitis </em>group*</p><p><em>Streptococcus oralis*</em></p><p><em>Streptococcus pneumoniae</em></p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;Aerobic gram-negative bacteria:</p><p><em>Haemophilus influenzae</em></p><p>&nbsp;</p><p>*Efficacy for these organisms were studied in fewer than 10 infections.</p><p>&nbsp;</p><p><strong>CLINICAL STUDIES</strong></p><p>In two randomized, double-masked, multicenter clinical trials, where patients 1-89 years of age were dosed for 5 days, ZYMAXID&reg; was clinically superior to its vehicle on day 6 in patients with conjunctivitis and positive conjunctival cultures.&nbsp; Clinical outcomes for the trials demonstrated clinical success (resolution of conjunctival hyperemia and conjunctival discharge) in 58% (193/333) of patients for the gatifloxacin-treated groups versus 45% (148/325) for the vehicle-treated groups.&nbsp; Microbiological outcomes for the same clinical trials demonstrated a statistically superior eradication rate for causative pathogens of 90% (301/333) for gatifloxacin vs. 70% (228/325) for vehicle.&nbsp; Please note that microbiological eradication does not always correlate with clinical outcome in anti-infective trials.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Gatifloxacin ophthalmic solution 0.5% was administered to one eye of 6 healthy male subjects each in an escalated dosing regimen starting with a single 2 drop dose, then 2 drops 4 times daily for 7 days, and finally 2 drops 8 times daily for 3 days.&nbsp; At all time points, serum gatifloxacin levels were below the lower limit of quantification (5 ng/mL) in all subjects.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Carcinogenesis</p><p>There was no increase in neoplasms among B6C3F1 mice given gatifloxacin in the diet for 18 months at doses averaging 81 mg/kg/day in males and 90 mg/kg/day in females. These doses are approximately 175-fold higher than the maximum recommended ophthalmic dose (MRHOD) of 0.04 mg/kg/day ZYMAXID&nbsp;in a 60 kg human (on a mg/m2 basis).</p><p>A statistically significant increase in the incidence of large granular lymphocyte (LGL) leukemia was seen in male rats treated with 100 mg/kg/day (approximately 405-fold higher than the MRHOD, on a mg/m2 basis).&nbsp; Fischer 344 rats have a high spontaneous background rate of LGL leukemia and the incidence in high-dose males only slightly exceeded the historical control range established for this strain. There was no increase in neoplasms among Fischer 344 rats given gatifloxacin in the diet for 2 years at doses averaging 47 mg/kg/day in males and 139 mg/kg/day in females (approximately 190- and 560-fold higher than the MRHOD, respectively), on a mg/m2 basis.</p><p>&nbsp;</p><p>Mutagenesis</p><p>In genetic toxicity tests, gatifloxacin was positive in 1 of 5 strains used in bacterial reverse mutation assays: Salmonella strain TA102.&nbsp; Gatifloxacin was positive in in vitro mammalian cell mutation and chromosome aberration assays.&nbsp; Gatifloxacin was positive in in vitro unscheduled DNA synthesis in rat hepatocytes but not human leukocytes.&nbsp; Gatifloxacin was negative in in vivo micronucleus tests in mice, cytogenetics test in rats, and DNA repair test in rats.&nbsp; The genotoxic findings are similar to findings obtained with other quinolones and may be due to the pharmacologic inhibitory effects of high concentrations of gatifloxacin on eukaryotic type II DNA topoisomerase.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>benzalkonium chloride 0.005%</p><p>edetate disodium</p><p>sodium chloride</p><p>&nbsp;purified water</p><p>&nbsp;hydrochloric acid and/or sodium hydroxide to adjust pH.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not known.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Unopened: 24 months
Discard 28 days after first opening


            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store at 15&deg;-25&deg;C . Protect from freezing.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&nbsp;ZYMAXID<strong>&nbsp;</strong>(gatifloxacin ophthalmic solution) 0.5% is supplied sterile in a white, low density &nbsp;&nbsp;polyethylene (LDPE) bottle with a controlled dropper tip, and a tan, high impact polystyrene (HIPS) cap in the following size:</p><p>2.5 mL in 5 mL bottle</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No special requirements.</p><p>Any unused medicinal product or waste material should be disposed of in accordance with local requirements</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Allergan Inc., Irvine, USA
Telephone: 800-347-4500
Fax: (714) 796-3015

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                09/2016
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>